Transforming Multiomics Spatial Tissue Biology with the Power of MALDI Mass Spectrometry for Imaging Targeted Proteins, Lipids, Glycans and Metabolites
Transforming Multiomics Spatial Tissue Biology with the Power of MALDI Mass Spectrometry for Imaging Targeted Proteins, Lipids, Glycans and MetabolitesWATERTOWN, Mass. (BUSINESS WIRE) Boston-area life science technology company AmberGen Inc. today announced that it has closed a strategic investment by Bruker Corpo.